Xijing Hospital: Stomach Neoplasms trials

The registry lists 10 Stomach Neoplasms studies with Xijing Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract CancersRecruitingNCT07600125
• Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric CancerRecruitingNCT06979895
• The Efficacy and Safety of Benmelstobart for GC/EGCNot yet recruitingNCT06603974Not applicable
• Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric CancerNot yet recruitingNCT06459921Phase 2
• The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of GastricRecruitingNCT05956847
• Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric JunctionActive, not recruitingNCT06576921Phase 2
• ERAS in Totally Laparoscopic Total Gastrectomy for Gastric CancerActive, not recruitingNCT06489288Not applicable
• An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGCStatus unknownNCT05800080Not applicable
• Clinical Study of 68Ga Labeled HER2 Affibody AnaloguesStatus unknownNCT05411432Early Phase 1
• Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric CancerStatus unknownNCT05385900Not applicable